medicine-technology-1/pharmacyclics-to-present-at-merriman-curhan-fords-investor-summit-2009-6080-2/;+health+history;+medical+history.html

Breaking Biology Technology:NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2 NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3 Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2 Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3 Biomatrica Launches SampleWare 3.1 2 Biomatrica Launches SampleWare 3.1 3 Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 2 Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors 3

[0] NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont [0] Brooks Instrument Appoints Mike Bayda as Global Level Product Manager [0] Biomatrica Launches SampleWare 3.1 [0] Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors

Breaking Medicine Technology:Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2 Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3 Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4 Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2 Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3 Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5 GreenHouse Energy Governor Schwarzenegger Join in Driving the Future of Fueling in California 12478 1 GreenHouse Energy Governor Schwarzenegger Join in Driving the Future of Fueling in California 12478 2 GreenHouse Energy Governor Schwarzenegger Join in Driving the Future of Fueling in California 12478 3 PLC Systems Announces Appointment of Louis Brenner M D to Board of Directors 48005 1 PLC Systems Announces Appointment of Louis Brenner M D to Board of Directors 48005 2 Global Testing Shows No Variation in Swine Flu Virus 48002 1 Global Testing Shows No Variation in Swine Flu Virus 48002 2 Global Testing Shows No Variation in Swine Flu Virus 48002 3 Global Testing Shows No Variation in Swine Flu Virus 48002 4 Global Testing Shows No Variation in Swine Flu Virus 48002 5 Global Testing Shows No Variation in Swine Flu Virus 48002 6 Global Testing Shows No Variation in Swine Flu Virus 48002 7 Global Testing Shows No Variation in Swine Flu Virus 48002 8 Global Testing Shows No Variation in Swine Flu Virus 48002 9 Global Testing Shows No Variation in Swine Flu Virus 48002 10 Global Testing Shows No Variation in Swine Flu Virus 48002 11

[0] Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders [0] Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy [0] Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy